Table 2. Number (%) with treatment failure in each treatment group over the 11 month observation period, by sex, age group and village.
8-week Placebo | 14-day PQ | 8-week PQ | |
All | 22/71 (31.0) | 1/55 (1.8) | 4/74 (5.1) |
Male | 10/41 (24.4) | 0/24 | 2/35 (5.7) |
Female | 12/29 (41.4) | 1/31 (3.2) | 2/38 (5.3) |
Age Group | |||
3–10 | 15/46 (32.6) | 1/30 (3.3) | 4/38 (10.5) |
11–20 | 7/20 (35.0) | 0/19 | 0/23 |
>20 | 0/5 | 0/6 | 0/13 |
Village | |||
Adizai | 18/27 (66.7) | 1/30 (3.3) | 4/43 (9.3) |
Baghicha | 4/33 (12.1) | 0/23 | 0/23 |
Khagan | 0/11 | 0/2 | 0/8 |